“Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker”. Advances in World Medical Research 1, no. 2 (December 31, 2025): 48–63. Accessed February 11, 2026. https://awmr.cscholar.com/article/view/1000360.